Transmission of symptomatic parvovirus B19 infection by fibrin sealant used during surgery

Citation
M. Hino et al., Transmission of symptomatic parvovirus B19 infection by fibrin sealant used during surgery, BR J HAEM, 108(1), 2000, pp. 194-195
Citations number
10
Categorie Soggetti
Hematology,"Cardiovascular & Hematology Research
Journal title
BRITISH JOURNAL OF HAEMATOLOGY
ISSN journal
00071048 → ACNP
Volume
108
Issue
1
Year of publication
2000
Pages
194 - 195
Database
ISI
SICI code
0007-1048(200001)108:1<194:TOSPBI>2.0.ZU;2-9
Abstract
Human parvovirus B19 infection has been shown to be transmissible by blood and blood products and to result in transient aplastic crisis in patients w ith rapid red cell turnover. We report three cases of iatrogenic parvovirus B19 infection resulting from the use of the same batch of fibrin sealant u nder operation, Fibrin sealant, which is a typical haemostatic agent produc ed from blood, has been used during surgery. Human parvovirus is resistant to existing virus-inactivating techniques, suggesting that infection may oc cur from blood products contaminated with it. Use of recombinant products f or these proteins may thus he necessary.